to page content
to site navigation
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
Leaving presentations to chance is like embarking on a trip without a map (hat tip to Amanda Schnieders for the metaphor). If you don't know where you're headed and how you'll get there, you may not reach your destination.
President Obama bet his legacy and the nation on the creativity, energy and drive of the American people. His entire persona is that of a man bent on creating a better future, placing the long and short bets that will insure the US remains the most vital and creative nation in the history of the world. His faith in American ingenuity and the abilities of the people to innovate and create fill every speech he makes. In particular four areas are the focus of his belief that Americans can lead the world into a brighter tomorrow; clean energy, communications, medicinal technology and space development.
Be it encouraging the development of a US clean energy industry, supporting our amazing internet and communications entrepreneurs, developing new ways to save lives and make Americans healthier at lower cost, or catalyzing a vital new commercial space industry to follow in NASA's footsteps and open the frontier to the people, in each of these areas the president is pursuing initiatives that are transformative.
This exceptional article offers insightful explanation and key details of how angel investors determine valuations, why entrepreneurs and investors often have different perspectives for angel returns, and what steps angels and entrepreneurs can take to quickly find common ground on this critical topic.
Investing in seed and startup companies is extremely risky: Angel investors typically realize about 85 percent of their total portfolio returns from 15 percent of their portfolio companies. Consequently, angels look only for companies that can grow rapidly. Entrepreneurs who pursue less aggressive growth are unlikely to attract angel investors.
An important voice in the angel investing world, Luis Villalobos has contributed a practical new term--"valuation divergence"--that focuses on a little understood fact of angel investing: Returns on investments in a company do not increase in direct proportion to the company's market valuation. Entrepreneurs and investors alike will benefit from a better understanding of this concept.
A new biomedical endowment at Duke University will support a program that has already launched new healthcare businesses. Read more to find out about Duke’s successes in commercializing medical technology.
The venture capital climate improved in RTP in the first quarter, but biotech companies are still competing for dollars. Several RTP companies saw venture capital investment for development of pharmaceutical products and medical technologies. Read more to learn about the venture capital climate.
Hatteras Venture Partners, a venture capital firm, will invest $20 million to $30 million in helping companies through first-in-man and preclinical studies. The firm expects to invest in 10 to 15 companies in the healthcare business.
A North Carolina startup is taking on the problem of counterfeit drugs. The company’s technology embeds a tiny tag into the medicine itself that allows for identification and authentication to fight fraudulent pharmaceuticals.
A startup company with a new way to make nanofibers sees many potential applications in the medical business. Xanofi has the technology to make strides in several industries, including the healthcare business.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.